Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye

Progress in Retinal and Eye Research

Volumn 20, Issue 3, 2001, Pages 319-349

  Flammer, Josef ^a   Pache, Mona ^a   Resink, Thérèse ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETAXOLOL; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; ENDOTHELIN 1; FISH OIL; GLYCERYL TRINITRATE; MAGNESIUM; NITROPRUSSIDE SODIUM; PAPAVERINE; PROPRANOLOL; UROKINASE; VERAPAMIL;

ANGIOGRAPHY; ARTERY GRAFT; CLINICAL FEATURE; CORNEA EDEMA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GLAUCOMA; HUMAN; MICROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; REVIEW; TRANSITIONAL BLINDNESS; VASOSPASM;

CONSTRICTION, PATHOLOGIC; EYE; EYE DISEASES; HUMANS; PERIPHERAL VASCULAR DISEASES;

EID: 0035077836     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1350-9462(00)00028-8     Document Type: Review

References (285)

1. Radio-immuno assay estimation of plasma endothelin levels in patients with bilharzial and post viral liver cirrhosis: A possible new additive factor in aggravation of portal hypertension
2. Optic disc haemorrhages precede retinal nerve fibre layer defects in ocular hypertension
3. Type-A behavior and coronary vasospasm: A possible role of hypomagnesemia
4. Changes in plasma endothelin during coronary spasm
5. Arterial disease and thrombosis in the antiphospholipid syndrome: A pathogenic role for endothelin 1
6. Spasm of the retinal vessels in association with unstable primary angina
7. Spontaneous recovery of vision in progressive anterior ischemic optic neuropathy
8. Coronary spastic angina in middle-aged women: A psychosomatic disorder?
9. Nonocclusive mesenteric ischemia
10. X-recessive angiopathic opticopathy
11. Differential diagnosis of acral blood circulation disorders using intra-arterial DSA of the hand
12. The cumulative defect curve: Separation of local and diffuse components of visual field damage
13. Retinal vasospasm associated with visual disturbance in preeclampsia: Color flow Doppler findings
14. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients
15. Combined central retinal vein occlusion and cilioretinal artery occlusion associated with prolonged retinal arterial filling
16. Vasospastic amaurosis fugax
17. Fluctuating hearing losses in children can be migraine equivalents
18. Fundus oculi changes in chronic ischemia of the lower extremities
19. Acrocyanosis in anorexia nervosa
20. Syndrome of intestinal arterial insufficiency ("abdominal angina")
21. Ein Fall von schwerer Flimmer-Migräne mit retinalen Angiospasmen
22. Relationship between blood flow velocities in retrobulbar vessels and laser Doppler flowmetry at the optic disk in glaucoma patients
23. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study
24. Occlusion of the ophthalmic artery in Crohn disease
25. Glaucoma and vasospasm
26. Transient monocular blindness caused by vasospasm
27. Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome
28. Nonocclusive ischemic colitis secondary to hemorrhagic shock
29. Coronary artery spasm after coronary artery bypass grafting
30. Color Doppler ultrasonography in ocular Behcet's disease
31. Chronic open angle glaucoma and low tension glaucoma: Endothelin-1 levels in plasma and aqueous humour
32. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse
33. Transient orbital ischemic syndrome
34. Effect of topical vasodilators on gastroepiploic artery graft
35. Functional visual loss in children: A common problem with an easy solution
36. Life events and visual symptoms of Adolf Hitler
37. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone
38. Migraine and tension headache in high-pressure and normal-pressure glaucoma
39. Risk factors for visual field damage progression in normal-tension glaucoma eyes
40. Bilateral transient visual obscurations with headaches during α-II interferon therapy: A case report
41. Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries
42. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective study
43. Central retinal vein occlusion during remission of ulcerative colitis
44. Elevated glutamate levels: The vitreous body of humans and monkeys with glaucoma
45. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: Effects of AT1/AT2 antagonists
46. Acute myocardial infarction in two adolescent males
47. Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis
48. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: The role of endothelin
49. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120
50. Magnesium deficiency and sudden death
51. Papillophlebitis: Benign retinopathy resembling papilledema or papillitis
52. Ophthalmologic findings in patients with sudden deafness
53. Acute myocardial infarction in a young woman with systemic lupus erythematosus
54. Generalized vasculopathy and finger blood flow abnormalities in rheumatoid arthritis
55. Angiotensin, thirst, and sodium appetite
56. Anterior ischemic optic neuropathy following the use of a nasal decongestant
57. Fluctuations in the visual field
58. Vasospasm as a potential factor in the pathogenesis of normal tension glaucoma
59. Psychophysical mechanisms and treatment of vasospastic disorders in normal-tension glaucoma
60. Therapeutical aspects of normal-tension glaucoma
61. The vascular concept of glaucoma
62. To what extent are vascular factors involved in the pathogenesis of glaucoma?
63. Die Behandlung des Normaldruckglaukoms mit Kalziumantagonisten
64. Endothelin in the pathogenesis of glaucoma
65. Auge und Psyche
66. The concept of vascular dysregulation in glaucoma
67. Lebersche hereditäre Optikusneuropathie: Genetisches Schicksal oder vermeidbare Erkrankung?
68. The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma
69. Behandlung choroidaler Vasospasmen mit Kalziumantagonisten
70. Do ocular vasospasms help cause low-tension glaucoma?
71. Vascular dysregulation: A principal risk factor for glaucomatous damage
72. Vision disorders to vascular dysregulation
73. Optic nerve blood-flow abnormalities in glaucoma
74. Ocular vasospasm. 1: Functional circulatory disorders in the visual system, a working hypothesis
75. Central retinal vein occlusion in young adults (papillophlebitis)
76. Familial migraine and coronary artery spasm in two siblings
77. Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine
78. Occlusion of the central retinal vein in migraine
79. Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome
80. Raised plasma endothelin-I concentration following cold pressor test
81. Influence of nifedipine on the visual foelds of patients with optic nerve head diseases
82. The influence of magnesium on visual field and peripheral vasospasm in glaucoma
83. Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients
84. Capillary blood cell velocity in finger nailfold: Characteristics and reproducibility of the local cold response
85. The role of nailbed vasospasm in Crohn's disease
86. Influence of vasospasm on visual function
87. Short- and long-term effect of nifedipine on the visual field in patients with presumed vasospasm
88. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma
89. Do vasospasms provoke ocular diseases?
90. Bedeutung des vasospastischen Syndroms in der Augenheilkunde
91. Relationship between blood-flow velocities in the ophthalmic artery and in nailfold capillaries
92. Is vascular regulation in the central retinal artery altered in persons with vasospasm?
93. Endothelium-dependent changes in retinal blood flow following ischemia
94. Relationship between corneal temperature and finger temperature
95. Choroidal vascular abnormality in Purtscher's retinopathy shown by indocyanine green angiography
96. Homocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects
97. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
98. Mesenteric and peripheral vascular ischemia secondary to ergotism
99. Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat
100. The relationship between digital and ocular vasospasm
101. Vasospasm, vascular injury, and atherogenesis: A perspective
102. Risk factors in central retinal vein occlusion and activated protein C resistance
103. Recurrent anterior ischemic optic neuropathy in young adults
104. Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates
105. Transcranial Doppler findings of cerebral vasospasm in preeclampsia
106. Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine
107. Reversal of the vasospastic component of lupus vasculopathy by infusion of prostaglandin E1
108. Temporal arteritis and sensorineural hearing loss
109. Injection of vasodilators into arterial grafts through cardiac catheter to relieve spasm
110. Cold-induced acral vasospasm in migraine as assessed by nailfold video-microscopy: Prevalence and response to migraine prophylaxis
111. Coronary artery vasospasm: The likely immediated cause of acute myocardial infarction
112. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma
113. Familial evidence of vasospastic angina and possible involvement of HLA-DR2 in susceptibility to coronary spasm
114. Acute myocardial infarction due to vasospasm in a 13-year-old-boy
115. Unilateral painful vasospasm in the lower limbs of young women
116. Plasma endothelin-1 concentrations in patients with retinal vein occlusions
117. Exercise-induced transient visual events in young healthy adults
118. Migraine and benign positional vertigo
119. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin
120. Methamphetamine-induced ischemic colitis
121. Glutamate elevation in rabbit vitreous during transient ischemia-reperfusion
122. Ocular vasospasm in children
123. Vasospasm - A risk factor for nonarteriitic anterior ischemic optic neuropathy?
124. Endothelin-1 plasma levels in normal-tension glaucoma: Abnormal response to postural changes
125. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause
126. Blood flow velocity in the extraocular vessels in chronic smokers
127. Short-term effect of dipyridamole on blood flow velocities in the extraocular vessels
128. Preconditioning of coronary artery against vasoconstriction by endothelin-1 and prostaglandin F2alpha during repeated downregulation of epsilon-protein kinase C
129. Coronary artery spasm: A hypothesis on prevention by progesterone
130. Circadian rhythm of automatic nervous function in patients with normal-tension glaucoma compared with normal subjects using ambulatory electrocardiography
131. Bilateral sequential migrainous ischemic optic neuropathy
132. Migrainous central retinal artery occlusion
133. Migrainous ischemic optic neuropathy
134. Vasospasmus: A rare manifestation of homocystinuria
135. Anorexia and bulimia nervosa
136. Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique
137. Combined central retinal vein occlusion and cilioretinal artery occlusion associated with prolonged retinal arterial filling
138. Retinal vascular disease in ulcerative colitis
139. Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia
140. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis
141. Lower level of endothelin-1 in migraine with aura
142. Reversible cardiogenic shock in an angry woman - Case report and review of the literature
143. Adamantiadis-Behcet syndrome: Fluorescein angiography and choroid ischemia
144. Transient cortical blindness and bioccipital brain lesions in two patients with acute intrmittent porphyria
145. Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination
146. Amlodipine and beazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: Effects of a low and high dose combination
147. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension
148. Cyclic variation in onset of central retinal vein occlusion
149. Retinal detachment in postpartum preeclampsia and eclampsia: Report of two cases
150. Ocular symptoms in association with antiphospholipid antibodies
151. Increased plasma levels of endothelin-1 in patients with hyperthyroidism
152. High plasma levels of endothelin-1 in untreated Addison's disease
153. Prinzmetal's angina and emotions: A neglected psychosomatic entity
154. Ocular manifestations of cardiovascular and hematologic disorders
155. Antioxidants prevent elevation in [Ca(2+)](i) induced by low extracellular magnesium in cultured canine cerebral vascular smooth muscle cells: Possible relationship to Mg(2+) deficiency-induced vasospasm and stroke
156. Extracellular magnesium regulates effects of vitamin B6, B12 and folate on homocysteinemia-induced depletion of intracellular free magnesium ions in canine cerebral vascular smooth muscle cells: Possible relationship to [Ca(2+)]i, atherogenesis and stroke
157. Coronary spasm in acute myocardial infarction
158. Gradual loss and recovery of vision in temporal arteritis
159. Ueber Vasopathie und Auge
160. Arteriitis temporalis (Riesenzellarteriitis)
161. Vasospastisches Syndrom bei junger Frau mit Migräne, Raynaud-Syndrom, Hirninfarkt und Herzinfarkt
162. Action of natural estrogens on the vessel wall: Molecular mechanisms and clinical implications
163. Occurrence of severe vasospasm following intraventricular hemorrhage from an arteriovenous malformation. Report of two cases
164. Local cooling test for clinical capillaroscopy in Raynaud's phenomenon, unstable angina, and vasospastic visual disorders
165. Characterization of cerebral hemodynamic phases following severe head trauma: Hypoperfusion, hyperemia, and vasospasm
166. Visual field losses in subjects with migraine headaches
167. Transient corneal opacification induced by cold in Raynaud's disease
168. Betaxolol, a βI-adrenoceptor antagonist, has an affinity for L-type Ca(2+) channels
169. Central vein thrombosis in younger patients
170. Raynaud syndrome following timolol-containing eyedrops
171. Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries
172. Effect of dipyridamol on vascular responses of porcine ciliary arteries
173. Effects of calcium-channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries
174. Is the variant angina the coronary manifestation of a generalized vasospastic disorder?
175. Increased production of endothelin-1 in patients with inflammatory arthritides
176. Pathophysiology of endothelin in the cardiovascular system
177. Angina pectoris caused by coronary microvascular spasm
178. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus
179. Doxorubicin, an RNA synthesis inhibitor, prevents vasoconstriction and inhibits aberrant expression of endothelin-1 in the cerebral vasospasm model of the rat
180. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
181. Vasospasm-induced myocardial infarction with sumatriptan
182. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis
183. Simultaneous multiple brain hemorrhage associated with migraine - A case report
184. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas
185. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade
186. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X
187. The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia
188. Transient cortical blindness in EPH gestosis caused by cerebral vasospasm
189. Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cells
190. Relationship beteen the effect of carbon dioxide inhalation or nilvadipine on orbital blood flow in normal-tension glaucoma
191. Thromboangiitis obliterans: A rare cause of a reversible raynaud's phenomenon
192. Anticardiolipin antibody aggravates cerebral vasospasm after subarachnoid hemorrhage in rabbits
193. Vasospasm and glaucoma
194. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage
195. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction
196. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia
197. Optic-disc hemorrhages: Cause or result of ischemia?
198. Perilimbal aneurysms of conjunctival vessels in glaucoma patients
199. Female preponderance in normal-tension glaucoma
200. Optic disc cupping in arteritic anterior ischemic optic neuropathy
201. Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis
202. Killer dreams
203. Acute myocardial infarction in a 16-year-old boy with no predisposing risk factors
204. Endothelium-derived factors as paracrine mediators of prostate cancer progression
205. Vasospastic amaurosis fugax in a patient with overlap collagenosis treated with nimodipine
206. Recovery of vision in a 47-year-old man with fulminant giant cell arteritis
207. Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
208. Choroidal angiography findings in patients with glaucoma-like visual-field defects
209. Choroidal capillary and venous congestion in central serous chorioretinopathy
210. Mikrozirkulationsstörungen als pathogenetischer Faktor des Glaukoms-wird der Verdacht zur Gewissheit?
211. Ocular vasospasm. 4: Clinical examples
212. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behet's disease
213. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats
214. Branch retinal artery occlusion in a young woman with Meniere's disease
215. Potential role for Ginkgo biloba extract in the treatment of glaucoma
216. Use of selective vasodilation in treatment of sickle cell disease
217. Gastrointestinal vascular ischemia caused by ergotamine
218. Digital necrosis in acquired immune deficiency syndrome vasculopathy treated with recombinant tissue plasminogen activator
219. Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome
220. A world record marathon runner with silent ischemia without coronary atherosclerosis
221. An adrenaline-induced vasospasm as the form of presentation of variant angina
222. Treatment of exercise-induced transient visual events
223. Light-induced ocular pain and visual obscurations in severe vasospastic disease
224. Regional cerebral blood flow during migraine
225. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm
226. Macular capillary hemodynamic changes associated with Raynaud's phenomenon
227. Microvasculatory evaluation of vasospastic syndromes
228. Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction
229. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: A study of urokinase concentration and the fibrinolytic system
230. Increase in choroidal blood flow in rabbits with endothelin-1 induced transient complete obstruction of retinal vessels
231. Visual loss following intranasal anesthetic injection
232. Cilioretinal artery occlusion in young adults with central retinal vein occlusion
233. Regional cerebral blood volume after severe head injury in patients with regional cerebral ischemia
234. Subarachnoid hemorrhage, cerebral ischemia and endothelin-1
235. Isolated benign cerebral vasculitis or migrainous vasospasm?
236. Refractory coronary artery spasm with superimposed thrombosis: Successful treatment with Palmaz-Schatz stent
237. Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation
238. Central retinal vein occlusion in a patient with anorexia nervosa
239. Platelet nitric oxide metabolites in migraine
240. Migraine with and without aura: The same disease due to cerebral vasospasm of different intensity. A hypothesis based on CBF studies during migraine
241. Bilateral ischemic optic neuropathy secondary to acute ergotism
242. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis
243. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage
244. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans
245. Pericorneal vascular changes as an expression of systemic vascular processes
246. Nailfold videocapillaroscopy abnormalities in patients with antiphospholipid antibodies
247. Microangiopathy of the brain and retina
248. Vasospastic angina in two sisters
249. Paraneoplastic Raynaud's phenomenon
250. Review: Immunobiology of preeclampsia
251. In vivo role of endothelin-converting enzyme-1 as examined by adenovirus-mediated overexpression in rats
252. Amaurosis fugax and ocular infarction in adolescents and young adults
253. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects
254. Lomerizine, a Ca(2+) channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
255. Gene transfer of calcitonin gene-related peptide to cerebral arteries
256. Spasme de l'a. Centrale de la retine
257. Lupus anticoagulants/anticardiolipin antibodies in patients with normal tension glaucoma
258. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium
259. Plasma endothelin-1 levels in Behet's disease
260. Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans
261. Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy
262. Endothelial dysfunction and atherosclerosis
263. Nailfold capillary microscopy in patients with anticardiolipin antibodies: A case-control study
264. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension
265. Migraine as a cause of sudden hearing loss
266. Silent myocardial ischemia in glaucoma and cataract patients
267. Ischemic optic neuropathy in migraine
268. Autoradiographic localization and analysis of endothelin-1 binding sites in human synovial tissue
269. Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension
270. Endothelins mediate intestinal hypoperfusion during bacteremia
271. Recovery from ocular ischemic syndrome after treatment with verapamil
272. Brief report: Treatment of vasospastic amaurosis fugax with calcium-channel blockers
273. Fourth nerve palsy in migraine
274. The role of the endothelium in modulating vascular control in sepsis and related conditions
275. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma
276. Endothelin-1 production by human synoviocytes
277. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese
278. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus
279. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon
280. Effect of Ox-LDL on endothelium-dependent response in pig ciliary artery: Prevention by an ET(A) antagonist
281. Endothelin in cerebral vasospasm. Clinical and experimental results
282. Mechanism of endothelin-1-induced contraction in rabbit basilar artery